trending Market Intelligence /marketintelligence/en/news-insights/trending/3nlgbnvefb_k3xkduwba8q2 content esgSubNav
In This List

Kura Oncology CFO to step down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Kura Oncology CFO to step down

Kura Oncology Inc. said Heidi Henson is stepping down as CFO and company secretary July 6 to pursue other opportunities.

Henson agreed to serve as a consultant to the company following her resignation. Troy Wilson, Kura Oncology's CEO and president, will act as interim principal financial officer and principal accounting officer following Henson's departure.

Henson had been serving as secretary and CFO of the San Diego-based cancer-drug maker since August 2014.

Kura Oncology said it is looking for a new CFO.